Bende M M, Bapat T R, Balsara J J, Chandorkar A G
Department of Pharmacology, V.M. Medical College, Solapur, Maharashtra.
Indian J Physiol Pharmacol. 1990 Jul;34(3):195-200.
In the present study we have investigated the effect of yohimbine on dopamine-dependent behaviours in rats and mice. Yohimbine (1.25 to 10 mg/kg, ip) failed to block the conditioned avoidance response in rats, to inhibit the traction response in mice and to induce catalepsy in rats and mice. Pretreatment with yohimbine (1.25 to 10 mg/kg, ip) had no significant effect on apomorphine stereotypy in rats and apomorphine induced cage climbing behaviour in mice. However, pretreatment with yohimbine (1.25 to 10 mg/kg. ip) significantly increased the intensity of methamphetamine stereotypy and antagonised haloperidol catalepsy in rats. Our findings indicate that yohimbine does not possess postsynaptic striatal and mesolimbic D-2 dopamine receptor blocking activity.
在本研究中,我们调查了育亨宾对大鼠和小鼠多巴胺依赖性行为的影响。育亨宾(1.25至10毫克/千克,腹腔注射)未能阻断大鼠的条件性回避反应、抑制小鼠的牵引反应以及诱导大鼠和小鼠的僵住症。育亨宾(1.25至10毫克/千克,腹腔注射)预处理对大鼠的阿扑吗啡刻板行为和小鼠的阿扑吗啡诱导的笼内攀爬行为没有显著影响。然而,育亨宾(1.25至10毫克/千克,腹腔注射)预处理显著增加了大鼠甲基苯丙胺刻板行为的强度,并拮抗了氟哌啶醇诱导的僵住症。我们的研究结果表明,育亨宾不具有突触后纹状体和中脑边缘D-2多巴胺受体阻断活性。